slotkoers
Andere beurzen
|
||
- USD | - |
|
08/07 | CASI Pharmaceuticals benoemt Daniel Lang CFO | MT |
08/07 | CASI Pharmaceuticals, Inc. benoemt Daniel Lang tot Senior Vice President | CI |
Omzet 2024 * | 19,8 mln. 18,12 mln. | Omzet 2025 * | 46,48 mln. 42,53 mln. | Marktkapitalisatie | 81,64 mln. 74,71 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -35 mln. -32,03 mln. | Nettowinst (verlies) 2025 * | -33 mln. -30,2 mln. | EV/omzet 2024 * | 4,12 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,76 x |
K/w-verhouding 2024 * |
-2,46
x | K/w-verhouding 2025 * |
-2,95
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 62,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 02-04-19 |
Wei Zhang
PSD | President | 64 | 01-09-18 |
Chun Hua Wang
COO | Chief Operating Officer | 52 | 01-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 02-04-19 |
Yue Wu
BRD | Director/Board Member | 62 | 01-04-13 |
Zhen Bo Su
BRD | Director/Board Member | 48 | 21-03-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,35% | 815 mld. | |
+31,96% | 597 mld. | |
-0,10% | 377 mld. | |
+15,47% | 319 mld. | |
+13,10% | 310 mld. | |
+12,84% | 250 mld. | |
+16,34% | 247 mld. | |
+16,54% | 180 mld. | |
+4,31% | 170 mld. |
- Beurs
- Aandelen
- Koers CASI
- Koers